Chemical activators of AMDHD1 can engage various intracellular signaling pathways to enhance the functional activity of this protein. The cyclic AMP (cAMP) pathway is one such target, where agents like N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate (dbcAMP) and Forskolin can elevate intracellular cAMP levels. This elevation in turn activates protein kinase A (PKA), a kinase that can phosphorylate and activate AMDHD1, resulting in an increase in its enzymatic activity. Similarly, 8-Bromo-cAMP, another cAMP analog, also activates PKA, fostering a conducive environment for the activation of AMDHD1. A-769662, an activator of AMP-activated protein kinase (AMPK), and 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR), an AMPK agonist, can also promote the phosphorylation of AMDHD1. AMPK is known to phosphorylate a variety of downstream targets, and its activation can lead to a cascade of phosphorylation events that may encompass the activation of AMDHD1.
Additionally, the protein kinase C (PKC) pathway is implicated in the activation of AMDHD1 through the action of Phorbol 12-myristate 13-acetate (PMA), which is a strong activator of PKC. PKC can directly phosphorylate AMDHD1, which is a post-translational modification that can increase the protein's activity. Okadaic acid, a serine/threonine phosphatase inhibitor, prevents the dephosphorylation of proteins, potentially leading to sustained kinase activity and subsequent phosphorylation and activation of AMDHD1. The role of cellular stress pathways in the activation of AMDHD1 is highlighted by Vinblastine and Paclitaxel, which disrupt or stabilize microtubules, respectively. These alterations in microtubule dynamics can activate stress-related signaling cascades that may include kinases capable of phosphorylating AMDHD1. Lastly, Spermine, by modulating polyamine signaling, can influence intracellular phosphorylation states that may favor the activation of AMDHD1, and 1,9-Dideoxyforskolin, a forskolin analog, can activate adenylyl cyclase, again leading to increased cAMP and activation of PKA, which in turn can phosphorylate and activate AMDHD1. Each of these chemicals, through their unique mechanisms, plays a role in the activation of AMDHD1 by influencing the protein's phosphorylation state and enzymatic activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
dbcAMP is a membrane-permeable cAMP analog that can activate protein kinase A (PKA). PKA activation can lead to phosphorylation events that activate AMDHD1 by enhancing its enzymatic activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC can phosphorylate AMDHD1, resulting in its functional activation. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662 is an AMP-activated protein kinase (AMPK) activator. AMPK activation can lead to phosphorylation events that may directly activate AMDHD1. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an AMPK agonist, which can phosphorylate downstream targets that may include AMDHD1, leading to its activation. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor, but as a side effect, it can affect other kinases. It may inadvertently activate AMDHD1 by altering the balance of kinase and phosphatase activities. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a serine/threonine phosphatase inhibitor. By preventing dephosphorylation, it can result in the sustained activation of kinases that phosphorylate AMDHD1, leading to its activation. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can influence polyamine signaling pathways that modulate phosphorylation states within cells. This can lead to the activation of AMDHD1 by altering the phosphorylation balance. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cAMP analog that activates PKA. PKA can phosphorylate and activate AMDHD1. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine can disrupt microtubule dynamics, which can indirectly activate stress-related pathways that may involve the activation of AMDHD1. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can activate stress-related pathways. These pathways can lead to the activation of kinases that phosphorylate AMDHD1, resulting in its activation. | ||||||